Diabetes board on OH

[wanttolose]

Someone who hasn't left OH needs to pop into the diabetes forum as there is a thread there titled "double diabetes" where someone states that the RnY is the only proven surgery that cures type 2 diabetes. I don't have links to stats and studies but I know this to be not entirely correct and given that I haven't had surgery yet I am not the most credible poster on this. But if someone could, it would be great to give the poster some pointers....

[jillybean720]

Thanks for the heads up - on it!

[Gail R]

Thanks, I didn't even know there was a diabetes board. I need to check it out.

[sherbearmama]

Here is what I wrote:
Post Date: 1/4/12 1:24 pm
"The RNY has proven to cure type 2's.. the only thing that has been proven to cure it. "


You are absolutely incorrect. The articles below show that the Duodenal Switch cures Diabeties as well or BETTER than the RNY. Just read the conclusions and you'll see.

1. " Bileopancreatic Diversion with Duodenal Switch Lowers Both Early and Late Phases of Glucose, Insulin and Proinsulin Responses After Meal."

www.dsfacts.com/Type-2-Diabetes-Cure.html


2. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.
Prachand et al. Feb 2010
PubMed Abstract

OBJECTIVE: Increased body mass index is associated with greater incidence and severity of obesity-related comorbidities and inadequate postbariatric surgery weight loss. Accordingly, comorbidity resolution is an important measure of surgical outcome in super-obese individuals. We previously reported superior weight loss in super-obese patients following duodenal switch (DS) compared to Roux-en-Y gastric bypass (RYGB) in a large single institution series. We now report follow-up comparison of comorbidity resolution and correlation with weight loss.

METHODS: Data from patients undergoing DS and RYGB between August 2002 and October 2005 were prospectively collected and used to identify super-obese patients with diabetes, hypertension, dyslipidemia, and gastroesophageal reflux disease (GERD). Ali-Wolfe scoring was used to describe comorbidity severity. Chi-square analysis was used to compare resolution and two-sample t tests used to compare weight loss between patients whose comorbidities resolved and persisted.

RESULTS: Three hundred fifty super-obese patients [DS (n=198), RYGB (n=152)] were identified. Incidence and severity of hypertension, dyslipidemia, and GERD was comparable in both groups while diabetes was less common but more severe in the DS group (24.2% vs. 35.5%, Ali-Wolfe 3.27 vs. 2.94, p

Sher--the bear mama

JOIN ME HERE weightlosssurgery.proboards.com/index.cgi

[wanttolose]

I hope the original poster reads the new inputs!

[sherbearmama]

I also sent her a private message letting her know that she's welcome to come over here where the veterans are to get much more accurate information. :-)